(S)-4-Benzyl-2-(thiophen-2-yl)-4,5-dihydrooxazole, 97%, 1g

6-BROMO-[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE, 97.0%, 5g

2,3-Difluoro-6-iodobenzaldehyde, 5g

(3S,4R,5R)-3,4,5,6-TETRAHYDROXY-1-MORPHOLINOHEXAN-2-ONE, 97%, 1g

5-Piperidin-1-ylmethyl-furan-2-carboxylic acid, 95.0%, 50mg

(2S)-3-Methyl-2-(pyrrolidin-1-yl)butanoic acid, 98+%, 100mg

(S)-2-(2-(Diphenylphosphanyl)phenyl)-4-isopropyl-5,5-diphenyl-4,5-dihydrooxazole, 98%, 1g

5-chloro-3-methyl-1-phenyl-1H-pyrazole, 95%, 100mg

Lente IOS E-plan EPLi 4x/0,10 con corrección de infinito. Distancia de trabajo 18,9 mm

(2S)-2-(4-(((2-Amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid, 67%, 100mg

1-(3,4-Dimethoxy-phenyl)-3-dimethylamino-propenone, 250mg

3-(2,4-Dichlorophenyl)-1-ethyl-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

tert-Butyl 2-hydroxy-7-azaspiro[3.5]nonane-7-carboxylate, 95.0%, 250mg